TY - JOUR
T1 - Myocardial Injury on CMR in Patients With COVID-19 and Suspected Cardiac Involvement
AU - Vidula, Mahesh K.
AU - Rajewska-Tabor, Justyna
AU - Cao, J. Jane
AU - Kang, Yu
AU - Craft, Jason
AU - Mei, Winifred
AU - Chandrasekaran, Preethi S.
AU - Clark, Daniel E.
AU - Poenar, Ana Maria
AU - Gorecka, Miroslawa
AU - Malahfji, Maan
AU - Cowan, Eilidh
AU - Kwan, Jennifer M.
AU - Reinhardt, Samuel W.
AU - Al-Tabatabaee, Sarah
AU - Doeblin, Patrick
AU - Villa, Adriana D.M.
AU - Karagodin, Ilya
AU - Alvi, Nazia
AU - Christia, Panagiota
AU - Spetko, Nicholas
AU - Cassar, Mark Philip
AU - Park, Christine
AU - Nambiar, Lakshmi
AU - Turgut, Alper
AU - Azad, Mahan Roosta
AU - Lambers, Moritz
AU - Wong, Timothy C.
AU - Salerno, Michael
AU - Kim, Jiwon
AU - Elliott, Michael
AU - Raman, Betty
AU - Neubauer, Stefan
AU - Tsao, Connie W.
AU - LaRocca, Gina
AU - Patel, Amit R.
AU - Chiribiri, Amedeo
AU - Kelle, Sebastian
AU - Baldassarre, Lauren A.
AU - Shah, Dipan J.
AU - Hughes, Sean G.
AU - Tong, Matthew S.
AU - Pyda, Malgorzata
AU - Simonetti, Orlando P.
AU - Plein, Sven
AU - Han, Yuchi
N1 - Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
PY - 2023/5
Y1 - 2023/5
N2 - BACKGROUND: Myocardial injury in patients with COVID-19 and suspected cardiac involvement is not well understood.OBJECTIVES: The purpose of this study was to characterize myocardial injury in a multicenter cohort of patients with COVID-19 and suspected cardiac involvement referred for cardiac magnetic resonance (CMR).METHODS: This retrospective study consisted of 1,047 patients from 18 international sites with polymerase chain reaction-confirmed COVID-19 infection who underwent CMR. Myocardial injury was characterized as acute myocarditis, nonacute/nonischemic, acute ischemic, and nonacute/ischemic patterns on CMR.RESULTS: In this cohort, 20.9% of patients had nonischemic injury patterns (acute myocarditis: 7.9%; nonacute/nonischemic: 13.0%), and 6.7% of patients had ischemic injury patterns (acute ischemic: 1.9%; nonacute/ischemic: 4.8%). In a univariate analysis, variables associated with acute myocarditis patterns included chest discomfort (OR: 2.00; 95% CI: 1.17-3.40, P = 0.01), abnormal electrocardiogram (ECG) (OR: 1.90; 95% CI: 1.12-3.23; P = 0.02), natriuretic peptide elevation (OR: 2.99; 95% CI: 1.60-5.58; P = 0.0006), and troponin elevation (OR: 4.21; 95% CI: 2.41-7.36; P < 0.0001). Variables associated with acute ischemic patterns included chest discomfort (OR: 3.14; 95% CI: 1.04-9.49; P = 0.04), abnormal ECG (OR: 4.06; 95% CI: 1.10-14.92; P = 0.04), known coronary disease (OR: 33.30; 95% CI: 4.04-274.53; P = 0.001), hospitalization (OR: 4.98; 95% CI: 1.55-16.05; P = 0.007), natriuretic peptide elevation (OR: 4.19; 95% CI: 1.30-13.51; P = 0.02), and troponin elevation (OR: 25.27; 95% CI: 5.55-115.03; P < 0.0001). In a multivariate analysis, troponin elevation was strongly associated with acute myocarditis patterns (OR: 4.98; 95% CI: 1.76-14.05; P = 0.003).CONCLUSIONS: In this multicenter study of patients with COVID-19 with clinical suspicion for cardiac involvement referred for CMR, nonischemic and ischemic patterns were frequent when cardiac symptoms, ECG abnormalities, and cardiac biomarker elevations were present.
AB - BACKGROUND: Myocardial injury in patients with COVID-19 and suspected cardiac involvement is not well understood.OBJECTIVES: The purpose of this study was to characterize myocardial injury in a multicenter cohort of patients with COVID-19 and suspected cardiac involvement referred for cardiac magnetic resonance (CMR).METHODS: This retrospective study consisted of 1,047 patients from 18 international sites with polymerase chain reaction-confirmed COVID-19 infection who underwent CMR. Myocardial injury was characterized as acute myocarditis, nonacute/nonischemic, acute ischemic, and nonacute/ischemic patterns on CMR.RESULTS: In this cohort, 20.9% of patients had nonischemic injury patterns (acute myocarditis: 7.9%; nonacute/nonischemic: 13.0%), and 6.7% of patients had ischemic injury patterns (acute ischemic: 1.9%; nonacute/ischemic: 4.8%). In a univariate analysis, variables associated with acute myocarditis patterns included chest discomfort (OR: 2.00; 95% CI: 1.17-3.40, P = 0.01), abnormal electrocardiogram (ECG) (OR: 1.90; 95% CI: 1.12-3.23; P = 0.02), natriuretic peptide elevation (OR: 2.99; 95% CI: 1.60-5.58; P = 0.0006), and troponin elevation (OR: 4.21; 95% CI: 2.41-7.36; P < 0.0001). Variables associated with acute ischemic patterns included chest discomfort (OR: 3.14; 95% CI: 1.04-9.49; P = 0.04), abnormal ECG (OR: 4.06; 95% CI: 1.10-14.92; P = 0.04), known coronary disease (OR: 33.30; 95% CI: 4.04-274.53; P = 0.001), hospitalization (OR: 4.98; 95% CI: 1.55-16.05; P = 0.007), natriuretic peptide elevation (OR: 4.19; 95% CI: 1.30-13.51; P = 0.02), and troponin elevation (OR: 25.27; 95% CI: 5.55-115.03; P < 0.0001). In a multivariate analysis, troponin elevation was strongly associated with acute myocarditis patterns (OR: 4.98; 95% CI: 1.76-14.05; P = 0.003).CONCLUSIONS: In this multicenter study of patients with COVID-19 with clinical suspicion for cardiac involvement referred for CMR, nonischemic and ischemic patterns were frequent when cardiac symptoms, ECG abnormalities, and cardiac biomarker elevations were present.
KW - cardiac magnetic resonance (CMR)
KW - COVID-2019
KW - myocardial injury
KW - Predictive Value of Tests
KW - Myocarditis/pathology
KW - COVID-19/complications
KW - Magnetic Resonance Spectroscopy
KW - Humans
KW - Coronary Artery Disease
KW - Magnetic Resonance Imaging
KW - Troponin
KW - Heart Injuries
KW - Retrospective Studies
UR - http://www.scopus.com/inward/record.url?scp=85152746709&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85152746709&partnerID=8YFLogxK
U2 - 10.1016/j.jcmg.2022.10.021
DO - 10.1016/j.jcmg.2022.10.021
M3 - Article
C2 - 36752429
AN - SCOPUS:85152746709
SN - 1936-878X
VL - 16
SP - 609
EP - 624
JO - JACC: Cardiovascular Imaging
JF - JACC: Cardiovascular Imaging
IS - 5
ER -